Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit?
- 31 January 1998
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (1), 25-32
- https://doi.org/10.1016/s0959-8049(97)00317-1
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patientsGastroenterology, 1995
- Controlled trial of tamoxifen in patients with advanced hepatocellular carcinomaJournal of Hepatology, 1994
- Mechanisms of non-genotoxic carcinogenesisTrends in Pharmacological Sciences, 1994
- Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liverDigestive Diseases and Sciences, 1991
- Hepatic regenerationDigestive Diseases and Sciences, 1991
- Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifenJournal of Hepatology, 1990
- Estrogen Induction of Hepatocellular Carcinomas in Armenian HamstersHepatology, 1990
- Phase II trial of buserelin in hepatocellular carcinomaEuropean Journal of Cancer and Clinical Oncology, 1989
- Experimental studies on hepatocarcinogenesis of synthetic estrogen and progestogen with special reference to progression and biological characteristics of the developed hepatocellular carcinoma.Kanzo, 1989
- Sex hormone imbalance in male alcoholic cirrhotic patients with and without hepatocellular carcinomaCancer, 1988